Oct 18, 2022 / 12:30PM GMT
Operator
Good morning. Welcome to Synlogic's SynPheny-1 Phase II data release conference call. (Operator Instructions) Please be advised that the call is being recorded. I would now like to turn the call over to Andrew Funderburk of Kendall Investor Relations. Please proceed.
Andrew Funderburk;Kendall IR;Managing Director -
Thank you, operator. Good morning, and thank you for joining us on today's conference call. This morning, we issued a press release which outlines the positive top line results from the Phase II SynPheny-1 study. The release is available on the Investors section of our website at www.synlogictx.com.
As we begin, I'd like to remind everyone that comments today may include forward-looking statements made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date hereof and are subject to numerous factors, assumptions, risks and uncertainties, which change over time. Actual results could differ
Synlogic Inc Phase 2 Announcement Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
